Literature DB >> 8509797

Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

M Vrethem, T Skogh, J Ernerudh, B Ekstedt, O Andersen, J Lycke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8509797      PMCID： PMC489633          DOI： 10.1136/jnnp.56.6.721

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  5 in total

1.  Antibodies to myelin-associated glycoprotein are found in cerebrospinal fluid in polyneuropathy associated with monoclonal serum IgM.

Authors:  M Cruz; Y P Jiang; J Ernerudh; G Solders; T Olsson; P O Osterman; H Link
Journal:  Arch Neurol       Date:  1991-01

2.  Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.

Authors:  H P Hartung; K Reiners; B Schmidt; G Stoll; K V Toyka
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

3.  Antibodies to peripheral nerve myelin may occur without clinical neuropathy in healthy persons.

Authors:  M Vrethem; T Skogh; G Berlin; H Holmgren; J Ernerudh
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

4.  Neuropathy and anti-myelin-associated glycoprotein IgM M proteins: T cell regulation of M protein secretion in vitro.

Authors:  N Latov; M Godfrey; Y Thomas; E Nobile-Orazio; L Spatz; J Abraham; G Perman; L Freddo; L Chess
Journal:  Ann Neurol       Date:  1985-08       Impact factor: 10.422

5.  T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.

Authors:  H P Hartung; R A Hughes; W A Taylor; K Heininger; K Reiners; K V Toyka
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910
  5 in total
  4 in total

1.  Raised antibody titre against conjugated S-nitrosocysteine in IgM paraproteinaemic peripheral, neuropathy: possible role of nitric oxide in pathogenesis.

Authors:  A I Boullerne; E Ellie; J Demotes-Mainard; K G Petry
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

2.  Soluble interleukin-2 receptor levels in serum of patients with demyelinating polyneuropathy associated with monoclonal gammopathy.

Authors:  A J Larner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-01       Impact factor: 10.154

3.  Myelin protein P0-specific IgM producing monoclonal B cell lines were established from polyneuropathy patients with monoclonal gammopathy of undetermined significance (MGUS).

Authors:  M Kvarnstrom; E Sidorova; J Nilsson; C Ekerfelt; M Vrethem; O Soderberg; M Johansson; A Rosen; J Ernerudh
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

4.  Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells.

Authors:  Eva Hellqvist; Maria Kvarnström; Anita Söderberg; Magnus Vrethem; Jan Ernerudh; Anders Rosén
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.